Name: Latest research reports of Dr. Lal Pathlabs Ltd. authored by Karvy and published by - Trendlyne research reports.
Item: Dr. Lal Pathlabs Ltd.
Rating: 3
Author: Karvy

Dr. Lal Pathlabs Ltd.

NSE: LALPATHLAB | BSE: 539524 | ISIN: INE600L01024 | Industry: Healthcare Services
| Mid-range Performer

3051.8000 -62.70 (-2.01%)

NSE Nov 28, 2025 15:31 PM

33.06% Gain from 52W Low

Volume: 195.8K

Dr. Lal Pathlabs Ltd.

22 Aug 2019

3051.80

-2.01%

Dr. Lal PathLabs Ltd: Planned Expansions Boost Revenues

Hold: Dr. Lal Pathlabs Ltd.

Karvy

Dr Lal PathLabs (DLPL) Q1FY20 earnings came marginally higher than our estimates on account of improved revenue contribution from regions constituting

Dr. Lal Pathlabs Ltd. has an average target of 3111.40 from 5 brokers.